T37.1
Poisoning by, adverse effect of and underdosing of antimycobacterial drugs
Clinical Classification Guidelines
Excludes Type 1
- rifampicins (T36.6-)
- streptomycin (T36.5-)
Medical Intelligence & Overview
ICD-10 code T37.1 refers to cases of poisoning, adverse effects, or underdosing related to antimycobacterial drugs. These medications are primarily used to treat tuberculosis and other mycobacterial infections. While effective, they can sometimes cause adverse reactions or poisoning if not used properly. Recognizing the symptoms and understanding the causes can help in managing these situations effectively.
Causes & Symptoms
Clinical Causes: Accidental overdose of antimycobacterial medication Intentional overdose or misuse Adverse reactions due to side effects of the medication Underdosing leading to ineffective treatment and potential toxicity Poor medication adherence resulting in inconsistent drug levels Drug interactions increasing toxicity risk
Key Symptoms: Gastrointestinal issues such as nausea, vomiting, and abdominal pain Neurological symptoms like dizziness, headache, or confusion Hepatic symptoms including jaundice and elevated liver enzymes Skin reactions such as rashes or itching Muscle weakness or tremors Signs of nerve damage or peripheral neuropathy In severe cases, symptoms of organ failure or systemic toxicity
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of medical history review, particularly medication use, and physical examination. Laboratory tests may include blood tests to measure drug levels, liver function tests, and kidney function tests. In some cases, specific assays are used to detect drug toxicity. The healthcare provider considers symptoms, medication history, and any laboratory findings to confirm the diagnosis of poisoning or adverse effects related to antimycobacterial drugs.
Treatment Protocols: Management of poisoning or adverse effects involves supportive care tailored to the specific symptoms. This may include hydration, management of nausea and vomiting, and monitoring of vital functions. In cases of overdose, activated charcoal or other decontamination methods may be employed. Specific antidotes are rarely used but depend on the particular drug involved. Adjusting medication doses, switching drugs, or discontinuation may be necessary. Long-term follow-up is essential to monitor recovery and prevent further adverse effects.
Clinical Advice & FAQs
Billing Guidance
Is T37.1 a billable ICD-10 code?
Yes, T37.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T37.1?
Clinical documentation must specify the nature of Poisoning by, adverse effect of and underdosing of antimycobacterial drugs and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
